Investing Profile

Andrew Schwab

InvestorVCFounder
Founder & Managing Partner at 5AM Ventures
5amventures.comSan Francisco, California
Photo of Andrew Schwab, Managing Partner at 5am Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
5am Ventures Managing Partner
$100K - $5.0M
$1.5M
32
CompanyStageDateRound SizeTotal Raised
Escient Pharmaceuticals
Series CNov 2022$120M
Series BSep 2020$78M
Series AMay 2018$40M
$240M
Co-investors: Jason P. Hafler (Sanofi Ventures), JeenJoo Kang (The Column Group)
Novome Biotechnologies
Series BSep 2022$44M
Series AJan 2020$33M
SeedMar 2018$5M
$82M
Co-investors: Kiersten Stead (DCVC (Data Collective)), Dan Janney (Alta Partners)
CAMP4 Therapeutics
Series BJul 2022$100M
Series AJun 2021$45M
$180M
Co-investors: Jorge Conde (Andreessen Horowitz), Shaan C. Gandhi (Northpond Ventures)
Cleave Therapeutics
Series CAug 2019$12M
Series BAug 2016$37M
Series ANov 2011$42M
$100M
Co-investors: Robert Garland (New Enterprise Associates (NEA)), Carol Gallagher (New Enterprise Associates (NEA)), Kush Parmar (5am Ventures), Peter Thompson (OrbiMed), Marc Singer (Osage University Partners), Alfred Scheidegger (Nextech Invest), Larry Lasky (The Column Group)
BlueLight Therapeutics
Series BJan 2016$10M
Series AOct 2013$15M
$25M
Viveve
Post Ipo EquityMay 2015$12M
Series UnknownApr 2012$7M
Series UnknownApr 2010$4M
$23M
Bird Rock Bio
Series BMar 2014$15M
Series AMay 2009$13M
Series AJan 2009$25M
Series AApr 2008$8M
$61M
Co-investors: Richard Ulevitch (5am Ventures), Roel Bulthuis (INKEF Capital), Simeon J. George (SR One)
DVS Sciences
Series AJul 2011$15M
$15M